Amanda Roxburgh

indiana university bloomington

H指数:32

被引数:3,032

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Gender convergence of cannabis use, dependence, and risk in the US

美国大麻使用、依赖和风险的性别趋同

Social Science Research

IF3.5

2026-06-010

OAAI

Attitudes to Drug Policy in Australia, 2001–2022/23: What Does This Mean for Drug Policy Reform in Australia?

澳大利亚药物政策的态度，2001–2022/23：这对澳大利亚药物政策改革意味着什么？

Drug and Alcohol Review

IF2.6

2026-03-150

OAAI

Transforming Opioid Poisoning Surveillance Through Novel Technologies: Rationale and Methodological Protocol for Applying Natural Language Processing to Emergency Department Data

通过新技术转化阿片类药物中毒监测：将自然语言处理应用于急诊科数据的方法论方案和理由

Drug and Alcohol Review

IF2.6

2026-02-180

OAAI

Changing Drug Consumption Patterns Among Clients Attending the Medically Supervised Injecting Centre, Sydney: Implications for Service Provision and Harm Reduction Response

在悉尼医疗监督注射中心就诊客户中药物消费模式的变化：对服务提供和伤害减少响应的启示

Drug and Alcohol Review

IF2.6

2026-02-090

PRE

Initiation, cessation and resumption of attendance at the Melbourne supervised injecting room among a cohort of people who inject drugs

在墨尔本监督注射室中，药物注射人群队列的参与启动、停止与重新参与

International Journal of Drug Policy

IF4.4

2026-01-150

OAAI

Defining Public Amenity and Related Concepts in the Drug Consumption Room Literature: A Scoping Review

界定药物消费室文献中公共便利及其相关概念：一项范围综述

Drug and Alcohol Review

IF2.6

2026-01-140

PRE

Understanding Gender Differences in Injecting-Related Harms Among an Australian Sample of People Who Inject Drugs

理解澳大利亚注射药物使用者样本中与注射相关的性别差异危害

DRUG AND ALCOHOL REVIEW

IF2.6

2025-12-040

PRE

An age–period–cohort–interaction analysis of meth/amphetamine-related deaths in Australia, 2001–2020

2001—2020年澳大利亚甲基苯丙胺相关死亡年龄—时期—队列交互作用分析

Addiction

IF5.3

2025-07-010

PREAI

Analyses Updated to 2022–23 on Australian Attitudes Towards Supervised Injecting Facilities

更新至2022–23年的澳大利亚对监督注射设施的态度分析

Drug and Alcohol Review

IF2.6

2025-06-040

PRE

A Scoping Review of the Emergence of Novel Synthetic Opioids in Australian Drug Markets: What Does This Mean for Harm Reduction Responses?

澳大利亚药物市场中新型合成阿片类药物的出现：这对减少伤害的应对措施意味着什么？

DRUG AND ALCOHOL REVIEW

IF2.6

2025-05-280

Identification of nitazene-related deaths in Australia: How do we make it accurate and timely?

DRUG AND ALCOHOL REVIEW

IF2.6

2025-02-171

PRE

Characteristics of attrition within the SuperMIX cohort of people who inject drugs: a multiple event discrete-time survival analysis

BMC MEDICAL RESEARCH METHODOLOGY

IF3.4

2024-10-300

OAAI

Changes in Australians' attitudes towards supervised injecting facilities

DRUG AND ALCOHOL REVIEW

IF2.6

2024-09-020

The role of on-site drug analysis within supervised injecting facilities: A case presentation of an adverse event highlighting need

DRUG AND ALCOHOL REVIEW

IF2.6

2024-07-190

Improving assessment and management of suicide risk among people who inject drugs: A mixed methods study conducted at the Medically Supervised Injecting Centre, Sydney

DRUG AND ALCOHOL REVIEW

IF2.6

2024-07-090

OAAI

The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia

PUBLIC HEALTH

IF3.2

2023-11-010

PRE

The onset and severity of acute opioid toxicity in heroin overdose cases: a retrospective cohort study at a supervised injecting facility in Melbourne, Australia

CLINICAL TOXICOLOGY

IF3.3

2022-10-064

Twenty-one years at the Uniting Medically Supervised Injecting Centre, Sydney Australia: addressing the remaining questions

MEDICAL JOURNAL OF AUSTRALIA

IF8.5

2022-09-185

OAAI

Commentary on Skulberg et al.: Naloxone administration-finding the balance

对Skulberg等人的评论: 纳洛酮管理-找到平衡

ADDICTION

IF5.3

2022-04-071

Trends in MDMA-related mortality across four countries

ADDICTION

IF5.3

2021-04-1513

OAAI

Amanda Roxburgh

个人简介

教育背景

工作经历

荣誉奖项

研究方向